GO:1902255 positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator: Apoptosis Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902255 describes the biological process that activates or increases the intrinsic apoptotic signaling pathway specifically mediated by p53 class mediators.
• The term encompasses signal transduction events downstream of p53 that lead to mitochondrial outer membrane permeabilization and caspase activation.
• Key molecular players include p53 itself, HIC1, and other transcriptional regulators that modulate p53-dependent apoptosis.
• Dysregulation of this process is implicated in cancer, where loss of p53-mediated apoptosis promotes tumorigenesis, and in chemoresistance.
• Experimental models for studying GO:1902255 include CRISPR knockout, point mutation, and overexpression cell lines targeting p53 pathway components.
• Understanding this process aids in identifying therapeutic targets for cancers with aberrant p53 signaling and for modulating chemotherapy responses.
Description
The Gene Ontology term GO:1902255, positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator, defines any process that activates or increases the frequency, rate or extent of the intrinsic apoptotic signaling pathway mediated by p53 class mediators. This term is critical for researchers studying cell death mechanisms because it specifically captures the upstream regulatory events that converge on p53 to trigger mitochondrial apoptosis. The intrinsic apoptotic pathway, also known as the mitochondrial pathway, is essential for development, tissue homeostasis, and tumor suppression. p53, a tumor suppressor protein, acts as a central mediator that transcriptionally activates pro-apoptotic genes and directly interacts with mitochondrial effectors to promote apoptosis. The positive regulation of this pathway ensures that cells with irreparable DNA damage or oncogenic stress are eliminated, preventing malignant transformation. Consequently, defects in this process are associated with cancer, autoimmune diseases, and resistance to chemotherapy. This article provides a comprehensive overview of GO:1902255, integrating authoritative QuickGO definitions with real PubMed literature to support researchers in experimental design and therapeutic targeting.
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator At A Glance
| GO ID | GO:1902255 |
|---|---|
| GO term | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| Ontology | biological_process |
| Synonym | activation of intrinsic apoptotic signaling pathway by p53 class mediator; upregulation of signal transduction by p53 class mediator resulting in induction of apoptosis |
| Major function | Enhances p53-mediated mitochondrial apoptosis in response to cellular stress |
| Related pathways | Intrinsic apoptotic signaling pathway, p53 signaling pathway, DNA damage response |
| Cellular location | Cytoplasm, mitochondria, nucleus |
| Key mediators | p53, HIC1, BAX, BAK, PUMA, NOXA |
What Is GO:1902255?
GO:1902255 is a biological process term that refers to any process that activates or increases the frequency, rate or extent of the intrinsic apoptotic signaling pathway by p53 class mediator. In simpler terms, it covers the molecular events that enhance the ability of p53 or its class members to initiate apoptosis through the mitochondrial pathway. This includes signal transduction cascades, post-translational modifications, and transcriptional programs that amplify p53-dependent apoptotic signaling.
Why Is positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator Important in Cell Biology?
GO:1902255 is important because it defines the regulatory node where p53 class mediators amplify intrinsic apoptosis, a process critical for tumor suppression and response to genotoxic therapies. Dysregulation of this pathway leads to uncontrolled cell survival, contributing to cancer development and chemoresistance. Understanding the positive regulation of p53-mediated apoptosis provides insights into how cells decide between survival and death, which is fundamental for developing targeted cancer treatments and for predicting patient responses to chemotherapy.
• Central to tumor suppression by eliminating damaged or oncogene-activated cells.
• Modulates sensitivity to chemotherapy and radiotherapy in multiple cancers.
• Involved in developmental processes requiring programmed cell death.
• Dysregulation linked to autoimmune diseases and neurodegeneration.
• Target for pharmacological activation in p53-wild-type tumors.
• Key for understanding resistance mechanisms in p53-mutant cancers.
• Provides biomarkers for apoptosis competency in clinical samples.
• Enables functional genomics screens to identify novel regulators.
What Happens During positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator?
Stress Sensing and p53 Activation
In simple terms: When a cell is stressed, p53 is turned on to start the self-destruct program.
Various cellular stresses, such as DNA damage, oxidative stress, or oncogene activation, trigger post-translational modifications of p53 that stabilize and activate it as a transcription factor. This activation is a prerequisite for the positive regulation of intrinsic apoptotic signaling by p53 class mediators. Kinases such as ATM and ATR phosphorylate p53, disrupting its interaction with MDM2 and allowing it to accumulate in the nucleus.
Transcriptional Activation of Pro-apoptotic BCL-2 Family Genes
In simple terms: p53 turns on genes that make the cell's power plants leak, leading to death.
Activated p53 binds to promoters of pro-apoptotic genes including PUMA, NOXA, BAX, and BID, increasing their transcription. These BCL-2 family proteins then translocate to mitochondria to permeabilize the outer membrane. This step is a key component of the positive regulation because it amplifies the apoptotic signal through transcriptional upregulation.
Mitochondrial Outer Membrane Permeabilization (MOMP)
In simple terms: The mitochondria break open, releasing factors that kill the cell.
BAX and BAK oligomerize on the mitochondrial outer membrane, forming pores that release cytochrome c and other apoptogenic factors into the cytosol. This MOMP is considered the point of no return in the intrinsic apoptotic pathway. p53 can also directly interact with BAX and BAK to promote their activation, representing a non-transcriptional positive regulation.
Caspase Activation and Apoptosome Formation
In simple terms: Released factors assemble a death machine that activates executioner enzymes.
Cytochrome c binds to APAF-1, forming the apoptosome, which recruits and activates caspase-9. Caspase-9 then cleaves effector caspases-3 and -7, leading to cellular dismantling. This cascade is the downstream execution phase that is positively regulated by p53-mediated signaling.
Feedback Amplification and Regulation
In simple terms: The death signal can be boosted by feedback loops to ensure the cell dies.
Caspase-mediated cleavage of BID generates tBID, which further activates BAX/BAK, creating a positive feedback loop. Additionally, p53 can be cleaved by caspases, generating a truncated form that amplifies apoptosis. These feedback mechanisms ensure robust activation of the intrinsic apoptotic pathway.
Key Genes Involved in GO:1902255 positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator
The following genes and proteins are central to the positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TP53 | Master transcription factor that activates pro-apoptotic genes and directly interacts with mitochondria | Most frequently mutated tumor suppressor; target for cancer therapy |
| HIC1 | Transcriptional repressor that modulates p53 activity; SNPs may affect function | Potential biomarker for cancer susceptibility |
| BAX | Pro-apoptotic BCL-2 family member; forms pores in mitochondrial membrane | Key effector of MOMP; knockout models used to study apoptosis |
| BAK | Pro-apoptotic BCL-2 family member; redundant with BAX | Essential for apoptosis in certain cell types |
| PUMA (BBC3) | BH3-only protein transcriptionally activated by p53 | Critical for p53-mediated apoptosis; knockout mice show resistance |
| NOXA (PMAIP1) | BH3-only protein that inhibits anti-apoptotic BCL-2 proteins | Modulates sensitivity to chemotherapy |
| BID | BH3-only protein activated by caspase cleavage to amplify MOMP | Links extrinsic and intrinsic apoptosis |
| APAF-1 | Forms apoptosome with cytochrome c to activate caspase-9 | Essential for intrinsic apoptosis; loss promotes tumorigenesis |
| Caspase-9 | Initiator caspase activated by apoptosome | Knockout leads to developmental defects and apoptosis resistance |
| Caspase-3 | Executioner caspase that dismantles cell | Marker of apoptosis; knockout affects cell death |
| MDM2 | E3 ubiquitin ligase that targets p53 for degradation | Amplified in cancers; target for MDM2 inhibitors |
| ATM | Kinase that phosphorylates p53 in response to DNA damage | Mutated in ataxia-telangiectasia; regulates p53 activation |
| ATR | Kinase that activates p53 in response to replication stress | Target for cancer therapy |
| Cytochrome c | Electron carrier that becomes apoptogenic when released | Released during MOMP; detected in apoptosis assays |
| SMAC/DIABLO | Mitochondrial protein that antagonizes IAPs | Promotes caspase activation; prognostic marker |
| XIAP | Inhibitor of apoptosis protein that blocks caspases | Overexpressed in cancers; target for SMAC mimetics |
| p21 (CDKN1A) | p53 target that can inhibit apoptosis or promote survival depending on context | Modulates cell cycle arrest vs apoptosis decision |
How Is positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator Regulated?
The positive regulation of intrinsic apoptotic signaling by p53 class mediator is tightly controlled at multiple levels. Post-translational modifications of p53, including phosphorylation, acetylation, and ubiquitination, determine its stability and transcriptional activity. MDM2 and MDMX negatively regulate p53 by promoting its degradation and inhibiting its transactivation function. Conversely, kinases such as ATM, ATR, and CHK1/2 phosphorylate p53 to disrupt MDM2 binding and enhance its pro-apoptotic activity. Additionally, the balance between pro-apoptotic and anti-apoptotic BCL-2 family proteins dictates whether MOMP occurs. Cellular stress pathways, including the DNA damage response and oncogenic stress, converge on p53 to tip the balance toward apoptosis. Pharmacological inhibitors of MDM2 or BCL-2 can further activate this pathway, highlighting its therapeutic potential.
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Li-Fraumeni syndrome, multiple cancers | Knockout or point-mutant cell lines (e.g., HCT116 p53-/-) |
| HIC1 | Cancer susceptibility, epigenetic silencing | CRISPR knockout in cancer cell lines |
| BAX | Colorectal cancer, chemoresistance | BAX knockout HCT116 cells |
| PUMA | Melanoma, lymphoma | PUMA knockout mice or cell lines |
| MDM2 | Amplified in sarcomas and other cancers | MDM2 overexpression models |
Cancer
Loss of p53 function or impaired positive regulation of intrinsic apoptosis is a hallmark of many cancers. Mutations in TP53 or amplification of MDM2 lead to evasion of apoptosis, allowing tumor cells to survive and proliferate. Additionally, reduced expression of pro-apoptotic BCL-2 family members such as PUMA or BAX is associated with chemoresistance. Restoring p53-mediated apoptosis is a major therapeutic strategy, including MDM2 inhibitors and gene therapy.
Chemoresistance
Many tumors with wild-type p53 still resist chemotherapy due to defects in the apoptotic machinery downstream of p53. For example, overexpression of anti-apoptotic proteins like BCL-2 or XIAP can block MOMP and caspase activation. Understanding the positive regulation of this pathway helps identify combination therapies that overcome resistance.
Neurodegeneration
Aberrant activation of p53-mediated apoptosis contributes to neuronal loss in neurodegenerative diseases such as Alzheimer's and Parkinson's. However, the role of positive regulation in this context is complex, as p53 can also promote survival under certain conditions. Modulating this pathway may offer neuroprotective strategies.
From positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate p53-mediated apoptosis? | CRISPR knockout of gene X in p53-wild-type cancer cells |
| Does a point mutation in HIC1 affect p53 binding? | Knock-in of mutant HIC1 using CRISPR |
| Can overexpression of BCL-2 block p53-induced apoptosis? | Overexpression of BCL-2 in p53-inducible cell lines |
| What is the role of p53 acetylation in apoptosis? | Knock-in of acetylation-deficient p53 mutants |
| How does MDM2 inhibition affect apoptosis? | Treatment of cells with MDM2 inhibitors (e.g., Nutlin-3) |
| Can we screen for novel regulators of p53 apoptosis? | Genome-wide CRISPR library screening |
How to Study the positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Genes affecting p53-mediated apoptosis | Identify novel regulators |
| RNA-seq | Transcriptional changes upon p53 activation | Discover p53 target genes |
| Western blot | Protein cleavage and expression | Validate apoptosis markers |
| Immunoprecipitation | Protein-protein interactions | Study p53 complexes |
| Flow cytometry | Apoptotic cell percentage | Quantify cell death |
| Live-cell imaging | Mitochondrial permeabilization dynamics | Visualize MOMP |
| CRISPR activation (CRISPRa) | Overexpression of candidate genes | Test sufficiency in apoptosis |
| CRISPR interference (CRISPRi) | Knockdown of candidate genes | Test necessity in apoptosis |
CRISPR Knockout Screens
Genome-wide CRISPR knockout screens can identify genes whose loss enhances or suppresses p53-mediated apoptosis. Cells expressing a p53-inducible apoptotic reporter are transduced with a lentiviral sgRNA library, and sgRNA enrichment is measured after apoptosis induction. This approach has uncovered novel regulators such as HIC1 and other chromatin modifiers.
RNA Sequencing (RNA-seq)
RNA-seq after p53 activation reveals transcriptional changes in pro-apoptotic and anti-apoptotic genes. It can identify p53 target genes and measure the impact of candidate regulators on the apoptotic transcriptome. Time-course experiments capture dynamic responses.
Western Blot and Immunoprecipitation
Western blotting detects cleavage of caspase-3, PARP, and other apoptotic markers. Immunoprecipitation can assess interactions between p53 and BCL-2 family proteins or cofactors. These methods validate findings from screens.
Flow Cytometry and Imaging
Flow cytometry with Annexin V/PI staining quantifies apoptosis. Mitochondrial membrane potential dyes (e.g., TMRE) measure MOMP. Live-cell imaging of cytochrome c-GFP release visualizes apoptosis dynamics.
How CRISPR Can Be Used to Study GO:1902255 positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator
Knockout
CRISPR knockout of genes such as TP53, BAX, or PUMA in cancer cell lines abolishes p53-mediated apoptosis, confirming their essential roles. Knockout models are used to dissect the contribution of individual pathway components.
Point Mutation
Introducing point mutations in TP53 (e.g., R175H, R273H) via CRISPR knock-in creates isogenic models to study loss-of-function or gain-of-function effects on apoptosis. Similarly, mutations in HIC1 can be modeled to assess impact on p53 regulation.
Knock-in
Knock-in of tagged versions of p53 (e.g., GFP-p53) allows live-cell imaging and proteomic analysis of p53 dynamics during apoptosis. Knock-in of acetylation or phosphorylation mutants helps define post-translational regulation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of pro-apoptotic genes like BAX or PUMA sensitizes cells to apoptosis. Overexpression of anti-apoptotic BCL-2 confers resistance, modeling chemoresistance.
How EDITGENE Supports positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator Research
Researchers studying positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator-related genes often need to determine whether a candidate gene is causally involved in apoptosis regulation or merely correlative. Functional validation through precise genome editing is essential to establish causality and to dissect molecular mechanisms. EDITGENE provides a comprehensive suite of CRISPR services tailored to apoptosis research, enabling the creation of knockout, point-mutant, knock-in, and overexpression cell models, as well as high-throughput library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator research.
Frequently Asked Questions About positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator
What is GO:1902255?
GO:1902255 is a Gene Ontology biological process term for any process that activates or increases the frequency, rate or extent of the intrinsic apoptotic signaling pathway by p53 class mediator.
What genes are involved in positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator?
Key genes include TP53, HIC1, BAX, BAK, PUMA, NOXA, BID, APAF-1, caspase-9, and MDM2, among others.
How does p53 mediate intrinsic apoptosis?
p53 transcriptionally activates pro-apoptotic BCL-2 family genes and can directly interact with mitochondria to promote MOMP and caspase activation.
What diseases are associated with defects in this pathway?
Cancer, chemoresistance, and neurodegeneration are linked to dysregulation of p53-mediated apoptosis.
What experimental models are used to study GO:1902255?
CRISPR knockout, point mutation, knock-in, and overexpression cell lines, as well as mouse models, are commonly used.
How can I screen for regulators of p53-mediated apoptosis?
Genome-wide CRISPR knockout or activation screens in p53-inducible apoptosis reporter cells can identify novel regulators.
What is the role of HIC1 in p53-mediated apoptosis?
HIC1 is a transcriptional repressor that modulates p53 activity; SNPs in HIC1 may affect its function and cancer susceptibility.
What methods measure intrinsic apoptosis?
Flow cytometry with Annexin V, mitochondrial membrane potential dyes, western blot for caspase cleavage, and live-cell imaging of cytochrome c release.
Can CRISPR be used to create p53 point mutations?
Yes, CRISPR knock-in can introduce specific TP53 mutations to model loss-of-function or gain-of-function effects.
What services does EDITGENE offer for apoptosis research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, library screening, and bioinformatics services.
Conclusion
GO:1902255, positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator, is a fundamental biological process that governs cell fate decisions in response to stress. Its precise regulation is critical for tumor suppression and therapeutic responses, and its dysregulation contributes to cancer and other diseases. Continued research using advanced CRISPR models and functional genomics will further elucidate the molecular players and provide new opportunities for therapeutic intervention.
References
- 1. Annanya A et al.. 2024. Computational Analysis of Single Nucleotide Polymorphisms in Human HIC1 Gene.. Cureus 16(3):e56664 PMID: 38646326
